What is ADMA Biologics's common stock, shares, outstanding?

ADMA Biologics (ADMA) reported common stock, shares, outstanding of $232.29M in Q1 2026.

How has ADMA Biologics's common stock, shares, outstanding changed year-over-year?

ADMA Biologics's common stock, shares, outstanding decreased by 2.6% year-over-year, from $238.53M to $232.29M.

What is the long-term trend for ADMA Biologics's common stock, shares, outstanding?

Over 5 years (2020 to 2025), ADMA Biologics's common stock, shares, outstanding has grown at a 17.8% compound annual growth rate (CAGR), from $104.9M to $237.87M.

ADMA Biologics ADMA Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

AbCellera Biologics Inc.ABCL

——

ZymeworksZYME

——

BiohavenBHVN

——

AmgenAMGN

——

DanaherDHR

——

Charles River LaboratoriesCRL

——

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's common stock, shares, outstanding?: ADMA Biologics (ADMA) reported common stock, shares, outstanding of $232.29M in Q1 2026.
How has ADMA Biologics's common stock, shares, outstanding changed year-over-year?: ADMA Biologics's common stock, shares, outstanding decreased by 2.6% year-over-year, from $238.53M to $232.29M.
What is the long-term trend for ADMA Biologics's common stock, shares, outstanding?: Over 5 years (2020 to 2025), ADMA Biologics's common stock, shares, outstanding has grown at a 17.8% compound annual growth rate (CAGR), from $104.9M to $237.87M.